The Hidden Cost of COVID-19: Focus on Antimicrobial Resistance in Bloodstream Infections
Open Access
- 16 May 2023
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 11 (5) , 1299
Abstract
Antibiotic resistance is one of the greatest growing public health threats and a worldwide priority. According to the WHO, drug-resistant diseases may cause 10 million deaths a year by 2050 and have a substantial impact on the global economy, driving up to 24 million people into poverty. The ongoing COVID-19 pandemic has exposed the fallacies and vulnerability of healthcare systems worldwide, displacing resources from existing programs and reducing funding for antimicrobial resistance (AMR) fighting efforts. Moreover, as already seen for other respiratory viruses, such as flu, COVID-19 is often associated with superinfections, prolonged hospital stays, and increased ICU admissions, further aggravating healthcare disruption. These events are accompanied by widespread antibiotic use, misuse, and inappropriate compliance with standard procedures with a potential long-term impact on AMR. Still, COVID-19-related measures such as increasing personal and environmental hygiene, social distancing, and decreasing hospital admissions could theoretically help the AMR cause. However, several reports have shown increased antimicrobial resistance during the COVID-19 pandemic. This narrative review focuses on this “twindemic”, assessing the current knowledge of antimicrobial resistance in the COVID-19 era with a focus on bloodstream infections and provides insights into the lessons learned in the COVID-19 field that could be applied to antimicrobial stewardship initiatives.Keywords
This publication has 98 references indexed in Scilit:
- Effectiveness of contact precautions against multidrug-resistant organism transmission in acute care: a systematic review of the literatureJournal of Hospital Infection, 2015
- Clinical characteristics of children and adults hospitalized for influenza virus infectionJournal of Microbiology, Immunology and Infection, 2014
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapyClinical Microbiology and Infection, 2011
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza PreparednessThe Journal of Infectious Diseases, 2008
- Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPEThe Journal of Infectious Diseases, 2008
- Comparison of Mortality Associated with Vancomycin-Resistant and Vancomycin-Susceptible Enterococcal Bloodstream Infections: A Meta-analysisClinical Infectious Diseases, 2005
- Community‐Acquired Methicillin‐ResistantStaphylococcus aureus:A Meta‐Analysis of Prevalence and Risk FactorsClinical Infectious Diseases, 2003
- Environmental Contamination Due to Methicillin-Resistant Staphylococcus aureus: Possible Infection Control ImplicationsInfection Control & Hospital Epidemiology, 1997